The administration of a third dose of the Covid-19 vaccine would be the only solution to control the epidemiological situation in Morocco. Professor Azzedine Ibrahimi believes that the restrictive measures seem to have shown their limits.
Given its alarming epidemiological picture of infections, as well as deaths, leading to additional pressure on its health system, a second field hospital is being set up in Marrakech to meet the growing need for hospital beds.
The Covid-19 vaccination campaign in Morocco is now extended to people aged 18 and over, the Ministry of Health announced.
Morocco received a batch of 700,000 doses of the Pfizer/BioNTech vaccine this Friday, August 13, 2021. This will allow the kingdom to vaccinate the youngest against the coronavirus.
Abdelfattah Chakib, a doctor at the Ibn Rochd University Hospital in Casablanca , also a member of the scientific and technical committee, says that 90% of patients in intensive care are not vaccinated against Covid-19. They are among the skeptics of vaccination.
The Moroccan Network for the Right to Health is pleading with the National Social Security Fund (CNOPS) for PCR tests to be reimbursed or free, not only to relieve Moroccans, but also to support the government’s policy calling for massive screening.
The use of a third dose of vaccine for certain people is still under study. For Moroccan scientists, the most urgent thing at the moment is to focus on ways to achieve collective immunity with the first two doses.
A new shipment of the Chinese Sinopharm vaccine is expected in Morocco next week. In total, two million doses will be received.
The Head of Government, Saâdeddine El Othmani , mentions the possibility of making vaccination against the coronavirus compulsory. A possibility that he had previously ruled out.
Morocco is grappling with its third wave of Covid-19 infections : 5,043 new Covid-19 cases were recorded as of August 9, 2021, according to figures from the Ministry of Health. A worsening of the epidemic that is manifested above all by a surge in cases and the saturation of intensive care services in certain hospitals.
BioNTech, a German biotechnology company specializing in the development and manufacture of active immunotherapies in the treatment of serious diseases, is betting on Africa to boost its production. In this sense, it plans to open a factory in one of the following five countries: Morocco , Egypt, South Africa, Tunisia or Senegal.
A field hospital is under construction in Guelmim-Oued Noun to cope with the explosion of Covid-19 cases that the entire region is experiencing.